281, Novartis Investigational vaccines — Dayton, Ohio

281, Novartis Investigational vaccines is a clinical research site located in Dayton, Ohio, United States 45409.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

281, Novartis Investigational vaccines has participated in 1 clinical trials.

Therapeutic areas: Influenza Virus.

Sponsors: Seqirus.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 281, Novartis Investigational vaccines?

281, Novartis Investigational vaccines has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 281, Novartis Investigational vaccines conducted?

281, Novartis Investigational vaccines has 1 clinical trials on record. Their work covers Influenza Virus.

Is 281, Novartis Investigational vaccines accredited by Crixeo Health?

281, Novartis Investigational vaccines has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 281, Novartis Investigational vaccines?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.